首页> 外文期刊>Journal of international management >Next-generation sequencing technology as a powerful detection and semi-quantitative method for herpes simplex virus type 1 in pediatric encephalitis
【24h】

Next-generation sequencing technology as a powerful detection and semi-quantitative method for herpes simplex virus type 1 in pediatric encephalitis

机译:下一代测序技术作为疱疹病毒1型在儿科脑炎中的强大检测和半定量方法

获取原文
获取原文并翻译 | 示例
           

摘要

This case report presents a 1-year-old boy from China, with sudden onset of fever, convulsion, and sleepiness, screened for viral DNA in blood and cerebrospinal fluid (CSF) sample using next-generation sequencing (NGS) to diagnose herpes simplex virus type 1 (HSV-1) encephalitis, further validated by PCR. After acyclovir treatment, the patient's symptom disappeared and HSV-1 DNA unique reads decreased from 4290 to zero in CSF, and from 23 to zero in blood detected by NGS. The clinical presentation and outcome were consistent with the pathogenic diagnostic results of NGS. NGS of CSF samples can be used as a diagnostic assay for HSV-1 encephalitis and also might be a semi-quantitative method for evaluation of treatment effect.
机译:本案报告介绍了来自中国的一名1岁的男孩,突然发烧,痉挛和嗜睡,使用下一代测序(NGS)筛查血液和脑脊液(CSF)样品中的病毒DNA,以诊断疱疹单纯疱疹 病毒类型1(HSV-1)脑炎,通过PCR进一步验证。 在Acyclovir治疗后,患者的症状消失,HSV-1 DNA独特的读数在CSF中从4290减少到零,并由NG检测到的血液中的23至零。 临床介绍和结果与NGS的致病性诊断结果一致。 CSF样品的NGS可以用作HSV-1脑炎的诊断测定,并且也可能是用于评估治疗效果的半定量方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号